Robert Bona

4.7k total citations · 1 hit paper
60 papers, 2.4k citations indexed

About

Robert Bona is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Bona has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 19 papers in Internal Medicine and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Bona's work include Venous Thromboembolism Diagnosis and Management (19 papers), Hemophilia Treatment and Research (12 papers) and Platelet Disorders and Treatments (11 papers). Robert Bona is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (19 papers), Hemophilia Treatment and Research (12 papers) and Platelet Disorders and Treatments (11 papers). Robert Bona collaborates with scholars based in United States, Canada and Italy. Robert Bona's co-authors include Bruce L. Davidson, Sam Schulman, Mark Crowther, Antonio L. Dans, Lori‐Ann Linkins, Lisa K. Moores, Frederick R. Rickles, Bernard R. Greenberg, Muhammad Wasif Saif and Jeffrey S. Ginsberg and has published in prestigious journals such as The Lancet, Blood and Annals of Internal Medicine.

In The Last Decade

Robert Bona

53 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment and Prevention of Heparin-Induced Thrombocytopenia

2012 660 citations Robert Bona et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Bona United States	27	1.2k	937	834	727	318	60	2.4k
B. Kemkes‐Matthes Germany	23	865 0.7×	897 1.0×	830 1.0×	642 0.9×	328 1.0×	78	2.1k
Gilles Pernod France	27	1.6k 1.3×	652 0.7×	678 0.8×	1.4k 2.0×	61 0.2×	139	2.9k
Jens Hammerstrøm Norway	22	1.2k 1.0×	737 0.8×	429 0.5×	688 0.9×	41 0.1×	68	2.5k
Jeannine Kassis Canada	25	1.5k 1.3×	756 0.8×	885 1.1×	868 1.2×	33 0.1×	64	2.6k
L. Grunebaum France	26	919 0.8×	608 0.6×	544 0.7×	560 0.8×	107 0.3×	82	3.8k
P de Moerloose Switzerland	22	843 0.7×	665 0.7×	309 0.4×	518 0.7×	55 0.2×	64	1.8k
Florian Posch Austria	31	1.3k 1.0×	405 0.4×	656 0.8×	869 1.2×	49 0.2×	136	3.6k
Eduardo Rocha Spain	27	688 0.6×	757 0.8×	440 0.5×	584 0.8×	40 0.1×	108	2.0k
Luca Spiezia Italy	31	912 0.7×	1.3k 1.4×	444 0.5×	484 0.7×	64 0.2×	146	3.4k
Arthur A. Trowbridge United States	17	1.2k 1.0×	256 0.3×	710 0.9×	923 1.3×	91 0.3×	32	1.8k

Countries citing papers authored by Robert Bona

Since Specialization

Citations

This map shows the geographic impact of Robert Bona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bona more than expected).

Fields of papers citing papers by Robert Bona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bona. The network helps show where Robert Bona may publish in the future.

Co-authorship network of co-authors of Robert Bona

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bona. A scholar is included among the top collaborators of Robert Bona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bona. Robert Bona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ito, Satoko, Robert Bona, Harlan M. Krumholz, et al.. (2025). Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis. Blood Advances. 9(24). 6237–6245. 1 indexed citations

Ito, Satoko, Jeremy N. Harvey, Jan Philipp Bewersdorf, et al.. (2025). Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A. Annals of Internal Medicine. 178(6). 819–828.

Hsia, Cyrus C., Kevin Rowan, Shih‐Han S. Huang, et al.. (2025). Successful treatment of Kimura disease with Mycophenolate Mofetil: a report of two cases and review of the literature. Rheumatology International. 45(9). 224–224.

Gu, Sean X., Vincent Schulz, Henry M. Rinder, et al.. (2024). Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies. Blood Cells Molecules and Diseases. 110. 102893–102893.

Feinn, Richard, et al.. (2024). Joint bleeds in mild hemophilia: Prevalence and clinical characteristics. Haemophilia. 30(2). 331–335. 2 indexed citations

Ito, Satoko, et al.. (2024). Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States. Blood. 143(22). 2332–2335. 3 indexed citations

Ito, Satoko, et al.. (2023). Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease. Blood. 142(Supplement 1). 3698–3698.

Li, Fangyong, Adrienne J. Burns, Noffar Bar, et al.. (2022). Association of iron infusion reactions with ABO blood type. European Journal Of Haematology. 109(5). 519–525.

Usmani, Saad Z., Linda Choquette, Robert Bona, et al.. (2018). Transient bacteremia induced by dental cleaning is not associated with infection of central venous catheters in patients with cancer. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 125(4). 286–294. 4 indexed citations

10.

Metersky, Mark L., Noel Eldridge, Yun Wang, et al.. (2015). Predictors of warfarin‐associated adverse events in hospitalized patients: Opportunities to prevent patient harm. Journal of Hospital Medicine. 11(4). 276–282. 13 indexed citations

11.

Bona, Robert, et al.. (2011). Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation. Advances in Therapy. 28(6). 460–472. 11 indexed citations

12.

Li, Zihai, 義行高橋, Bei Liu, et al.. (2005). Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia. Clinical Cancer Research. 11(12). 4460–4468. 89 indexed citations

13.

Saif, Muhammad Wasif, Robert Bona, & Bernard R. Greenberg. (2001). AIDS and Thrombosis: Retrospective Study of 131 HIV-Infected Patients. AIDS Patient Care and STDs. 15(6). 311–320. 92 indexed citations

14.

Bona, Robert, et al.. (2000). Warfarin Is Safe as Secondary Prophylaxis in Patients With Cancer and a Previous Episode of Venous Thrombosis. American Journal of Clinical Oncology. 23(1). 71–73. 29 indexed citations

15.

Medeiros, Bruno C., William N. Rezuke, Andrew Ricci, et al.. (2000). Kaposi’s Sarcoma following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia. Acta Haematologica. 104(2-3). 115–118. 25 indexed citations

16.

Giri, Satyendra, et al.. (1995). 1008-15 Effectiveness of Heparin for Prevention of Coagulation Factor Activation During Radiofrequency Catheter Ablation. Journal of the American College of Cardiology. 25(2). 361A–361A. 1 indexed citations

17.

Seremetis, Stephanie, LM Aledort, Tat‐San Lau, et al.. (1993). Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. The Lancet. 342(8873). 700–703. 45 indexed citations

18.

Clarke, Bryan J., Frederick A. Ofosu, Sampath Sridhara, et al.. (1992). The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Letters. 298(2-3). 206–210. 49 indexed citations

19.

Weinstein, Ralph E., Robert Bona, & Frederick R. Rickles. (1991). Continuous infusion of monoclonal antibody‐purified factor VIII. American Journal of Hematology. 36(3). 211–212. 28 indexed citations

20.

Schneiderman, Henry, et al.. (1986). Progressive pulmonary infiltrates in a man with erythroleukemia. Morbidity and Mortality Conferences of the University of Connecticut Health Center.. PubMed. 50(7). 443–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact